Clinical Core
- Institution
- University of Pennsylvania, PA
- Principal investigator
- Joel Synes Perlmutter
- Funding
- $2.3M
- Duration
- 2019–2029
Moonbase score
Still being scored
Abstract
CLINICAL CORE ABSTRACT This Clinical Core will implement first in human PET imaging with new radiotracers targeting α-synuclein (α-syn) and 4 repeat tau (4R tau). These two types of radiotracers are key for investigation of Parkinson disease (PD) and Multiple Systems Atrophy (MSA), diseases that have α-syn brain pathology, and Progressive Supranuclear Palsy (PSP) and frontotemporal dementias (FTD) that have 4R tau brain pathology. A critical part of these studies is the Clinical Core driven consensus diagnosis conferences to implement careful evaluation of each participant since MSA and PSP can be particularly difficult to diagnose clinically. This represents a critical step for understanding the clinical manifestations of these disorders and for developing new treatments for these and related neurodegenerative diseases.
LOADING MOONBASE SCORE
Questions for University of Pennsylvania
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Pennsylvania70
Epitranscriptomic regulation in the mammalian nervous system
Guo-Li Ming · $985K · 2024–2032
- NIH · University of Pennsylvania65
SCH: Computer Vision Algorithms to Detect Tics In Patients with Tourette Syndrome
Joseph Mcguire · $300K · 2023–2028
- NIH · University of Pennsylvania62
A multipronged, mRNA gene therapy approach to HIV cure
Edward Kreider · $486K · 2025–2030